Cognitive effects of mild traumatic brain injury in adults

1. Definition and classification of mild traumatic brain injury
2. Epidemiology and risk factors
3. Neurocognitive impairments and symptom profiles
4. Assessment methods and diagnostic challenges
5. Rehabilitation approaches and recovery trajectories

Mild traumatic brain injury (mTBI), commonly referred to as concussion, is defined as a traumatically induced alteration in brain function, typically caused by a blow to the head or a rapid acceleration-deceleration force. It is distinguished from moderate and severe traumatic brain injuries by the degree of neurological disruption and duration of symptoms. Clinically, mTBI is characterised by a Glasgow Coma Scale (GCS) score of 13 to 15, loss of consciousness less than 30 minutes, post-traumatic amnesia less than 24 hours, and normal structural imaging findings, such as on CT or MRI scans.

Despite being classified as “mild”, mTBI can lead to a wide range of cognitive and functional impairments, particularly in the immediate post-injury period. Alterations in mental status may include confusion, disorientation, difficulty concentrating, or memory problems—symptoms that reflect disruption in cognition and executive function. These disruptions are typically transient but in some cases may persist and be identified through formal cognitive testing or neuropsychological assessment.

The classification of mTBI can also be further stratified based on civilian versus sports-related or military-related contexts, as the mechanism of injury and patterns of cognitive impairment may differ. In sports-related mTBI, for example, repetitive concussions have raised concerns about cumulative effects on memory and attention. Similarly, blast-induced mTBI, which is more common among military personnel, may present distinct patterns of cognitive and emotional disruption compared to blunt-force trauma seen in civilian settings.

Advancements in neuropsychology have contributed to a more nuanced understanding of mTBI, prompting the adoption of subtypes that consider symptom clusters such as vestibular, ocular-motor, cognitive-fatigue, and emotional disturbances. This emerging classification framework supports more targeted intervention strategies and recognises the heterogeneity of post-mTBI outcomes.

Standardisation of diagnostic criteria remains an ongoing challenge, as symptom presentation can be subtle or overlap with psychiatric conditions like depression and anxiety. Furthermore, objective markers that accurately capture the presence and severity of mTBI-induced cognitive dysfunction are still under development, underscoring the importance of comprehensive clinical evaluation and cognitive testing in the diagnostic process.

Epidemiology and risk factors

The incidence of mild traumatic brain injury (mTBI) in adults has increased globally, with current epidemiological estimates suggesting that mTBI accounts for approximately 70–90% of all treated traumatic brain injuries. This high prevalence reflects both the ubiquity of potential causes and the growing awareness and diagnosis of milder forms of head trauma. Adults of all ages can be affected, but the risk is notably higher among certain demographic groups, such as young adults aged 18–29, older adults over the age of 65, and males, who consistently show higher rates of injury across most studies. The higher prevalence in older populations may in part be due to falls, often linked to age-related changes in balance and cognition.

Common causes of mTBI include falls, motor vehicle accidents, assaults, and sports-related incidents. In military contexts, blast injuries account for a significant portion of mTBIs, particularly among deployed personnel. Sports and recreational activities are also a considerable source, particularly in contact sports such as football, rugby, and boxing, where repeated impacts to the head contribute to cumulative cognitive burden. Understanding these aetiologies is central to developing targeted prevention strategies and informing public health interventions.

Several risk factors have been identified that influence both the likelihood of sustaining an mTBI and the trajectory of recovery. Previous history of TBI is one such factor, with individuals who have suffered a prior concussion being more susceptible to subsequent injuries and prolonged recovery times. Genetic predisposition, especially variants linked to neuronal repair and inflammation pathways—such as the APOE ε4 allele—has been explored in neuropsychology research as a potential modulator of post-injury outcome.

Pre-existing mental health conditions, including depression, anxiety, or attention disorders, may exacerbate mTBI symptoms and interfere with recovery, potentially due to overlapping symptomology as well as underlying vulnerabilities in brain function. Likewise, alcohol and substance use can increase the risk for injury and complicate post-injury cognition. In contrast, protective factors such as access to timely healthcare, higher cognitive reserve, and psychosocial support have been associated with better outcomes.

Environmental and occupational factors also play a role in mTBI risk. Individuals working in high-risk settings such as construction, law enforcement, or the military are more likely to be exposed to situations where mTBIs may occur. These settings also present unique challenges for early detection and cognitive testing, especially when symptoms may be dismissed or underreported due to stigma or occupational pressures.

The epidemiology of mTBI in adults reflects a complex interplay of biological, behavioural, and environmental variables. A thorough appreciation of these risk factors informs not only primary prevention efforts but also post-injury care by tailoring intervention and rehabilitation strategies based on an individual’s risk profile and injury context.

Neurocognitive impairments and symptom profiles

Adults who experience mild traumatic brain injury (mTBI) often report a diverse array of neurocognitive impairments, many of which may emerge immediately after injury and persist for days, weeks or, in some cases, months. The most frequently reported cognitive deficits include problems with attention, memory—particularly working memory and episodic memory—processing speed, and executive function. These disturbances are thought to result from disruptions to the frontal and temporal lobes, regions commonly associated with organising behaviour, recalling information, and sustaining focus.

Symptom profiles following mTBI can vary significantly across individuals, depending in part on the mechanism of injury, prior neurological health, and psychosocial background. Despite the relatively mild nature of the trauma, the neurological changes that ensue can disrupt complex processes of cognition, affecting the ability to manage everyday tasks and occupational responsibilities. In particular, deficits in divided attention and mental flexibility are common and may only become apparent during tasks demanding sustained cognitive effort.

In the early post-injury phase, individuals with mTBI might encounter transient feelings of confusion, mental fogginess, and impaired concentration. These symptoms are often accompanied by physical complaints such as headaches, dizziness, and sleep disturbances, which may worsen with cognitive exertion. This constellation of symptoms is commonly referred to as post-concussion syndrome (PCS), a term used to describe the persistence of symptoms typically beyond the expected period of neurological recovery.

From the perspective of neuropsychology, mTBI presents diagnostic challenges because many cognitive difficulties overlap with symptoms of mood disorders such as depression and anxiety. Emotional changes such as irritability, heightened sensitivity to stimulation, and reduced tolerance for stress are frequently observed, potentially complicating clinical assessment of cognitive function. Furthermore, subjective reports of cognitive impairment may not always align with findings from formal cognitive testing, highlighting the need for multifaceted assessment tools that consider both self-reported and objective performance indicators.

Subgroups of individuals, such as athletes and military personnel, may exhibit unique symptom trajectories following mTBI. Repeated concussions in sports are associated with cumulative cognitive decline, particularly affecting short-term memory and processing accuracy. Similarly, blast-related mTBI in military contexts has been linked to heightened impairments in attention and executive function, with emerging research suggesting potential neurobiological differences in injury patterns. These group-specific findings underscore the importance of context-specific approaches to evaluation and treatment.

In addition to cognitive impairments, emotional and behavioural symptoms frequently co-occur following mTBI. Apathy, mood lability, and decreased motivation are not uncommon and may reflect disruptions in brain networks responsible for emotional regulation. Fatigue—both physical and cognitive—can further hinder recovery by limiting an individual’s ability to engage in rehabilitation or return to work. These issues may not only reflect neurological injury but also psychological responses to impaired functioning and reduced autonomy.

Emerging research continues to explore the neural mechanisms underlying persistent cognitive symptoms after mTBI, with advanced imaging techniques and biomarker analysis offering novel insights into subtle brain changes not visible on standard MRI or CT scans. This work contributes to a more nuanced understanding of cognitive dysfunction within the field of neuropsychology and holds promise for improving diagnosis and guiding intervention strategies.

Assessment methods and diagnostic challenges

Assessment of mild traumatic brain injury (mTBI) poses considerable challenges due in large part to the often subtle and transient nature of its cognitive and neurological symptoms. Traditional imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) typically fail to detect microstructural damage, leading clinicians to rely on a combination of clinical history, self-reported symptoms, and cognitive testing to establish a diagnosis. However, each of these assessment approaches carries inherent limitations, particularly when it comes to the objectivity and sensitivity required to detect the nuanced effects of mTBI on cognition.

Neuropsychological assessment remains a cornerstone in the evaluation of mTBI-related cognitive impairments. Standardised tests are employed to quantify cognitive domains such as attention, memory, reaction time, and executive functioning. These assessments provide valuable information about a patient’s post-injury cognitive profile, especially when pre-injury baselines are available for comparison, as is often the case with athletes or military personnel who undergo routine pre-deployment screening. Nevertheless, the interpretation of neuropsychological results can be complicated by practice effects, symptom exaggeration, or underreporting, emphasizing the need for sociocultural and contextual awareness in clinical evaluation.

The subjective nature of symptom reporting is another notable obstacle. Individuals with mTBI may struggle to articulate their cognitive difficulties, particularly if their symptoms are subtle or emerge only under conditions of cognitive load. Conversely, psychological distress—such as anxiety, depression, or post-traumatic stress—may amplify perceived impairments without clear objective deficits, complicating the differentiation between primary neurological dysfunction and affective overlay. These diagnostic ambiguities necessitate cautious interpretation and often a multidisciplinary approach, integrating neuropsychology, neurology, and psychiatry.

Emerging diagnostic technologies offer promise in addressing some of these gaps. Advanced neuroimaging modalities, such as diffusion tensor imaging (DTI) and functional MRI (fMRI), can detect changes in white matter integrity and functional connectivity that may be missed by conventional scans. Although not yet routinely used in clinical settings, these tools provide greater insight into the neuropathological underpinnings of cognitive disturbances associated with mTBI. Additionally, fluid biomarkers, including serum levels of tau protein and neurofilament light chain, are under investigation as potential indicators of neuronal injury and may augment future diagnostic accuracy.

In both clinical and research settings, cognitive testing remains central to the assessment process, but its application is not without its challenges. Inter-individual variability in test performance can obscure subtle cognitive deficits, particularly among individuals with high cognitive reserve. Moreover, return-to-work or return-to-play decisions often hinge on results from brief screening tools, which might not fully capture the complexity of cognitive recovery. There is an ongoing need for the development of more sensitive, ecologically valid assessments that better reflect real-world demands on cognition.

Digital technologies, including computerised cognitive testing platforms and mobile symptom tracking applications, are increasingly being integrated into the assessment of mTBI. These tools can facilitate longitudinal monitoring and early detection of delayed recovery, while also enabling remote assessment in under-resourced or geographically distant populations. However, questions remain regarding their clinical validity and standardisation across diverse populations, reinforcing the necessity for further validation within the field of neuropsychology.

Diagnostic clarity is further complicated by the lack of universally accepted criteria for chronic post-concussive symptoms. The variabilities in symptom duration, fluctuating presentation, and differential comorbidities, such as sleep disorders or vestibular dysfunction, can obscure the clinical picture and hinder timely intervention. Although clinical guidelines and consensus statements from organisations such as the World Health Organization and the National Institute for Health and Care Excellence provide frameworks for diagnosis, implementation can vary widely across healthcare systems and providers.

Ultimately, the assessment of mTBI requires not only an understanding of the neurocognitive domains likely to be affected but also a recognition of contextual and psychosocial influences. A comprehensive approach—incorporating detailed patient history, standardised cognitive testing, advanced imaging where indicated, and multidisciplinary perspectives—offers the best chance of delineating the complex impact of mTBI on brain function and guiding appropriate interventions.

Rehabilitation approaches and recovery trajectories

Rehabilitation following mild traumatic brain injury (mTBI) focuses on restoring function, managing symptoms, and facilitating return to daily life. While the majority of individuals recover within days to weeks, a subset experience persistent cognitive, physical, and emotional symptoms that require more structured intervention. Rehabilitation strategies are informed by the principles of neuropsychology and aim to address impairments in cognition, such as attention, memory, and executive functioning, as well as associated emotional and behavioural issues.

Early intervention is considered critical in optimising recovery. Patient education shortly after injury can help normalise symptoms and reduce anxiety, which is known to exacerbate cognitive complaints. Information on pacing activities, managing fatigue, and avoiding symptom exacerbation is typically provided. This stage often involves advising limited screen time, rest from cognitively demanding work, and graded return to normal routines. For individuals with ongoing difficulties, referral to a multidisciplinary team may be necessary.

Multidisciplinary rehabilitation commonly involves collaboration between neurologists, neuropsychologists, physiotherapists, occupational therapists, and speech-language therapists. Neuropsychological approaches focus on remediation and compensation strategies for cognitive deficits. Remediation involves repetitive cognitive training exercises targeting specific domains such as attention or memory, often delivered through computer-based cognitive testing programmes. Compensation strategies aim to circumvent deficits—for instance, using mnemonic devices, diary systems, or smartphone reminders to support memory function.

Restoration of cognitive function can be supported through targeted therapies such as cognitive behavioural therapy (CBT), particularly where emotional dysregulation, anxiety, or depression are present. CBT has been shown to improve coping strategies and reduce perceived cognitive deficits, highlighting the interconnectedness of mental health and cognition. In some cases, psychotherapy is complemented by pharmacological treatment aimed at addressing sleep issues, mood instability, or persistent headaches—symptoms that can impede cognitive recovery.

Vestibular and ocular-motor deficiencies, which often coexist with cognitive symptoms in mTBI, are addressed through specialised physiotherapy interventions. Vestibular rehabilitation therapy (VRT) targets dizziness and balance problems, which can indirectly support cognitive rehabilitation by enabling more consistent participation in therapeutic activities. Integration of these approaches acknowledges the multifaceted symptoms of mTBI and reinforces the need for holistic, individualised care plans.

Recovery trajectories vary markedly among individuals. While young, otherwise healthy adults may experience full recovery within a few weeks, older adults and those with previous mTBIs or coexisting conditions may face prolonged or incomplete recovery. Prognosis is influenced by factors such as the rapidity with which activities are resumed, the presence of psychosocial support, and premorbid cognitive reserve. Repeated concussions, particularly in sports or military personnel, can lead to accumulative impairments and slower cognitive recovery, reinforcing the need for careful monitoring and cautious return-to-play protocols.

Guidelines now recommend a gradual stepwise return to work, education, or sport, guided by symptom monitoring and formal cognitive testing. In schools and workplaces, accommodations such as reduced hours, modified tasks, and scheduled breaks may aid in the reintegration of individuals experiencing residual cognitive fatigue or concentration issues. Functional outcome assessment forms a key component of rehabilitation planning, enabling realistic goal setting and adjustment of expectations over time.

In cases where cognitive and emotional symptoms persist beyond the typical recovery window, often defined as three months, clinicians may diagnose persistent post-concussive symptoms. Management may thus shift toward long-term strategies for coping and adaptation. Cognitive rehabilitation therapy (CRT) delivered by specialists in neuropsychology has shown promise in these cases, helping individuals adjust to their limitations while maximising available cognitive capacity.

The continued development of evidence-based interventions within neuropsychology is essential to refining rehabilitation protocols and supporting recovery. Digital health technologies, including mobile apps and remote therapy platforms, are offering new modes of cognitive testing and rehabilitation, particularly valuable for patients in remote areas or those unable to access regular in-person care. These innovations also allow longitudinal tracking of cognitive function and better adaptation of treatment plans across the recovery trajectory.